$ABBV
ABBVIE INC.
XNYS•Health Care•Pharmaceutical Preparations
Why is ABBV down today? It is at $243.79 (-0.98%), and our scanner flagged it 26 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ABBV spikes, and full due diligence on ABBV — key stats, earnings, dilution and insider activity. Free.
Get free $ABBV alerts the moment volume spikes
Our scanner flagged $ABBV 26 times in the last 30 days. Create a free account to track $ABBV, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $243.79
- Change today
- -0.98%
- Previous close
- $246.20
- 52-week range
- $190.75 – $267.47
- Market cap
- $435.06B
- Dividend yield
- 2.81% ($6.92)
- Institutional own.
- 85.45%
- Total held
- 85.5%
- Tradeable float
- 256.1M 14% of shares · after <1% insiders + 85% institutions
- Short interest
- 22.6M ▲ +3% vs prior · as of 2026-07-15
- Short % of float
- 8.8%
- Days to cover
- 3.5d
- Avg daily volume
- 6.4M
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Exchange
- XNYS
- 5m
- 0.3x
- 15m
- 0.5x
- 1h
- 0.5x
- 1D
- 0.1x
Get free ABBV + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $ABBV down today?
ABBV is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on ABBV today, peaking at 2.0x its normal volume. Fresh from the SEC: AbbVie Inc. filed an 8-K: Other Material Event. A material company disclosure like this is often the real catalyst behind a move of this size.
Likely catalystOther Material Event, from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
Insiders buying11 buys, 0 sells last 3 months (20/13 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Austin Roxanne S Director | Acquired (grant/award) | +1K | added 2.9% | 40K | n/a | May 8, 26 |
Burnside William H.L. Director | Acquired (grant/award) | +1K | added 4.1% | 28K | n/a | May 8, 26 |
Davis Jennifer L. Director | Acquired (grant/award) | +1K | added 44% | 4K | n/a | May 8, 26 |
Hart Brett J Director | Acquired (grant/award) | +1K | added 5.7% | 21K | n/a | May 8, 26 |
Roberts Rebecca B Director | Acquired (grant/award) | +1K | added 8.1% | 15K | n/a | May 8, 26 |
Waddell Frederick H Director | Acquired (grant/award) | +1K | added 3.9% | 30K | n/a | May 8, 26 |
Meyer Melody B Director | Acquired (grant/award) | +1K | added 6.8% | 18K | n/a | May 8, 26 |
Freyman Thomas C Director | Acquired (grant/award) | +1K | added 0.9% | 128K | n/a | May 8, 26 |
Rapp Edward J Director | Acquired (grant/award) | +1K | added 2.5% | 46K | n/a | May 8, 26 |
Quaggin Susan E Director | Acquired (grant/award) | +1K | added 44% | 4K | n/a | May 8, 26 |
Falk Thomas J Director | Acquired (grant/award) | +1K | added 93% | 2K | n/a | May 8, 26 |
Purdue David Ryan Officer | Sold (automatic/other) | -5K | sold 66% | 3K | $1.2M at $233.56 | Mar 4, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Recent offeringRecent priced share offering — a one-time sale that has already completed (not ongoing). If $ABBV runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$ABBV Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$ABBV Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
ABBV is in these themes
Curated groups ABBV belongs to. Tap one to see every member with today's move and why the group is moving.
ABBV stock FAQ
Why is $ABBV down today?
ABBV is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on ABBV today, peaking at 2.0x its normal volume. Fresh from the SEC: AbbVie Inc. filed an 8-K: Other Material Event. A material company disclosure like this is often the real catalyst behind a move of this size.
What is the ABBV stock price today?
ABBV last traded at $243.79, down 0.98% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Does ABBV pay a dividend?
Yes. ABBV currently has a dividend yield of about 2.81% ($6.92 per share per year). Dividend figures can change; this is not investment advice.
Where can I see live ABBV alerts?
The ABBV Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ABBV 26 times in the last 30 days.
What exchange is ABBV on?
ABBV (ABBVIE INC.) trades on XNYS, with a market cap of about $435.06B in the PHARMACEUTICAL PREPARATIONS sector.
Is ABBV good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ABBV for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.